Quantitative serum tumor markers (CEA, CA19-9, and CA-125) are independently predictive of survival in patients with appendiceal adenocarcinoma

被引:0
|
作者
Shen, J. P. Y-C. [1 ]
Yousef, A. [1 ]
Yousef, M. M. G. [1 ]
Zeineddine, M. [1 ]
Chowdhury, S. [1 ]
Knafl, M. [2 ]
Raghav, K. [1 ]
White, M. G. [3 ]
Alfaro-Munoz, K. [1 ]
Helmink, B. [4 ]
Fournier, K. F. [4 ]
Overman, M. J. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Colon & Rectal Surg, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Surg Oncol, Houston, TX USA
关键词
D O I
10.1016/j.annonc.2023.09.2914
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
190P
引用
收藏
页码:S258 / S258
页数:1
相关论文
共 50 条
  • [1] Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma
    Zhang, Zongkai
    Li, Yin
    Wu, Ying
    Bi, Rui
    Wu, Xiaohua
    Ke, Guihao
    Zhu, Jun
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2023, 38 (3-4): : 223 - 232
  • [2] Predictive Value of Serum CEA, CA19-9 and CA-125 in Diagnosis of Liver Metastases from Colorectal Cancer in the Chinese Population
    Zhang, Di
    Yu, Mingxia
    Xu, Tangpeng
    Hu, Fen
    Li, Xiaogai
    Xiong, Bin
    [J]. HEPATO-GASTROENTEROLOGY, 2013, 60 (126) : 1297 - 1301
  • [3] Tissue expression of CEA, CA19-9, and CA125 serum markers in pseudomyxoma peritonei
    Nummela, P.
    Leinonen, H.
    Thiel, A.
    Jarvinen, P.
    Lepisto, A.
    Jarvinen, H.
    Ristimaki, A.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S3 - S3
  • [4] Clinical significance of serum CA-125, CA19-9 and CEA in pulmonary tuberculosis with and without type 2 diabetes
    Du, Zhi-xiang
    Liang, Man-man
    Sun, Jing
    Wang, Wen-jie
    Liu, Yin-hua
    Yang, Jiang-Hua
    [J]. TUBERCULOSIS, 2017, 107 : 104 - 110
  • [5] 肺癌血清CEA、CA-125、CA19-9联合检测的诊断价值
    杨刚
    何安南
    曹进平
    [J]. 皖南医学院学报, 2007, (03) : 181 - 182
  • [6] THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN OVARIAN-CANCER
    HOFFMANN, L
    MULLERHAGEN, S
    FRANZ, G
    KLAPDOR, R
    DIETEL, M
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 371 - 372
  • [7] Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer
    Yamao, T
    Kai, S
    Kazami, A
    Koizumi, M
    Handa, T
    Takemoto, N
    Maruyama, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (11) : 550 - 555
  • [8] The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
    Wang, Weigang
    Xu, Xiaoqin
    Tian, Baoguo
    Wang, Yan
    Du, Lili
    Sun, Ting
    Shi, Yanchun
    Zhao, Xianwen
    Jing, Jiexian
    [J]. CLINICA CHIMICA ACTA, 2017, 470 : 51 - 55
  • [9] LUMINESCENCE IMMUNOASSAYS OF THE TUMOR-MARKERS CA-125 AND CA-19-9
    REUM, L
    KLINGLER, W
    MARKOWITZ, G
    DRAHOVSKY, M
    PUCHINGER, B
    [J]. JOURNAL OF BIOLUMINESCENCE AND CHEMILUMINESCENCE, 1988, 2 (04): : 248 - 248
  • [10] DIAGNOSTIC-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125, CA-19-9, CA-15-3 AND CEA IN ENDOMETRIOSIS
    CIRKEL, U
    OCHS, H
    LATUSSEK, B
    SCHNEIDER, HPG
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1991, 51 (08) : 626 - 631